The urologist view of BPH progression: Results of an international survey

European Urology

Volumn 41, Issue 5, 2002, Pages 490-496

  Djavan, B ^a   Nickel, J C ^b   De La Rosette, J ^c   Abrams, P ^d  

^a UNIVERSITY OF VIENNA   (Austria)

^b QUEEN S UNIVERSITY   (Canada)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

BPH progression; PSA; Risk factors; Survey; Symptoms; Urodynamics

Indexed keywords

ADULT; ARTICLE; DISEASE COURSE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SYMPTOMATOLOGY; URINE FLOW RATE; URODYNAMICS;

ADULT; DISEASE PROGRESSION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; RISK FACTORS; TREATMENT OUTCOME; UROLOGY;

EID: 0036587079     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00065-9     Document Type: Article

References (16)

1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984:132:474-9.
2. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism: A population-based survey of urinary symptoms. J Urol 1993:150:85-9.
3. Ball A, Feneley RC, Abrams PH. The natural history of untreated prostatism. J Urol 1981;53:613-6.
4. Barry MJ, Fowler Jr FJ, Bin L, Pitts 3rd JC, Harris CJ. Mulley Jr AG. The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol 1997;157:10-4.
5. Jacobsen SJ, Jacobsen DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, Lieber MM. Natural history of prostatism: Risk factors for acute urinary retention. J Urol 1997;158:481-7.
6. Roberts RO, Jacobsen SJ, Jacobson DJ, Rhodes T, Girman CJ, Lieber MM. Longitudinal changes in peak urinary flow rates in a community-based cohort. J Urol 2000;163:107-13.
7. Roehrborn CG, McConnell JD, Lieber M, Kaplan S, Geller J, Malek GH, et al. Serum prostate-specific antigen is a powerful predictor of acute urinary retention and the need for surgery in men with clinical benign prostatic hyperplasia. Urology 1999;53:473-80.
8. Roehrbom CG, Boyle P, Bergner D, Gray T, Gittelman M, Shown T, et al. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: Results of a 4-year randomized trial comparing finasteride versus placebo. Urology 1999:54:662-9.
9. Marberger MJ, Andersen JT, Nickel JC, Malice MP, Gabriel M, Pappas F, et al. Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Eur Urol 2000:38:563-8.
10. Anderson JB, Roehrborn CG, Schalken JA, Emberton M. The progression of benign prostatic hyperplasia: Examining the evidence and determining the risk. Eur Urol 2001;39:390-9.
11. McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, et al. The effect of finasteride on the risk of AUR and the need for surgical treatment among men with benign prostatic hyperplasia. New Engl J Med 1998;338:557-63.
12. Barry MJ, The BPH Impact Index. In: Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G, editors. Proceedings of the Third International Consultation on BPH. Monaco, 26-28 June 1996. Scientific Communication International Ltd., 1996, pp. 275-6.
13. Barry MJ, Batista JE, Donovan J, Jonas U, Kurth KH, Lukacs B, et al. Measuring the symptoms and health impact of benign prostatic hyperplasia and its treatments. In: Chatelain C, Denis L, Foo KT, Khoury S, McConnell J, editors. Proceeedings of the Fifth International Consultation on Benign Prostatic Hyperplasia (BPH). Paris, 25-28 June 2000. Health Publication Limited. 2000, pp. 221-5.
14. Kawakami J, Nickel JC. Acute urinary retention and surgery for benign prostatic hyperplasia: The patient's perspective. Can J Urol 1999;6:819-22.
15. Garraway WM, Russell EB, Lee RJ, Collins GN, McKelvie GB. Hehir M. et al. Impact of previously unrecognised benign prostatic hyperplasia on the daily living activities of middle-aged and elderly men. Br J Gen Pract 1993:43:318-21.
16. Lee AJ, Garraway WM, Simpson RJ, Fisher W, King D. The natural history of untreated lower urinary tract symptoms in middle-aged and elderly men over a period of five years. Eur Urol 1998;34:325-32.